Council on Pharmacy and Chemistry (American Medical Association)

The Council on Pharmacy and Chemistry (CPC) was an organization established by the American Medical Association (AMA). Its primary function was to evaluate drugs and their therapeutic claims to protect the public from fraudulent or harmful products. The Council played a significant role in the early 20th century in standardizing medical treatments and ensuring the quality and efficacy of pharmaceuticals available to physicians and patients. It operated by examining evidence presented by manufacturers and making judgments on the acceptability of their products for inclusion in official compendia. This work was crucial in the development of a more regulated and trustworthy pharmaceutical market.

The Council on Pharmacy and Chemistry was an initiative undertaken by the American Medical Association. Formed in the early 20th century, its core mission was to address the widespread issue of unreliable and often dangerous medicinal preparations that were prevalent at the time. The Council aimed to provide a systematic and scientific approach to evaluating the vast array of drugs and treatments being marketed. By scrutinizing the claims made by manufacturers and assessing the scientific basis for these claims, the CPC sought to establish standards of purity, quality, and therapeutic value for pharmaceutical products.

The Council's process involved a thorough review of submitted drugs, requiring manufacturers to provide detailed information regarding their composition, therapeutic indications, and dosages. Products deemed acceptable based on scientific evidence and safety were then listed in the "New and Nonofficial Remedies" (NNR), a publication that served as a guide for physicians. This rigorous evaluation system helped to weed out fraudulent remedies and promote the use of scientifically validated medicines. The work of the CPC significantly contributed to the professionalization of medicine and the establishment of a more reliable drug market, laying groundwork for future regulatory efforts in pharmaceuticals.